ScoreWhy is Anhui Fengyuan Pharmaceutical Co., Ltd. ?
1
The company is Net-Debt Free
- Poor long term growth as Net Sales has grown by an annual rate of 1.70% and Operating profit at -3.15% over the last 5 years
- The company is Net-Debt Free
- The company has been able to generate a Return on Equity (avg) of 7.81% signifying low profitability per unit of shareholders funds
2
Poor long term growth as Net Sales has grown by an annual rate of 1.70% and Operating profit at -3.15% over the last 5 years
3
The company has declared negative results for the last 9 consecutive quarters
- OPERATING CASH FLOW(Y) Lowest at CNY 124.82 MM
- NET PROFIT(HY) At CNY 34.99 MM has Grown at -33.59%
- INTEREST(HY) At CNY 16.48 MM has Grown at 5.27%
4
Below par performance in long term as well as near term
- Along with generating -18.96% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Anhui Fengyuan Pharmaceutical Co., Ltd. for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
Anhui Fengyuan Pharmaceutical Co., Ltd.
-3.29%
-0.11
28.47%
China Shanghai Composite
3.0%
1.20
14.07%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
1.70%
EBIT Growth (5y)
-3.15%
EBIT to Interest (avg)
4.83
Debt to EBITDA (avg)
3.31
Net Debt to Equity (avg)
0.54
Sales to Capital Employed (avg)
1.26
Tax Ratio
25.17%
Dividend Payout Ratio
46.75%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
5.63%
ROE (avg)
7.81%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
25
Industry P/E
Price to Book Value
1.07
EV to EBIT
31.46
EV to EBITDA
15.21
EV to Capital Employed
1.04
EV to Sales
0.95
PEG Ratio
NA
Dividend Yield
1.92%
ROCE (Latest)
3.32%
ROE (Latest)
4.26%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend3What is working for the Company
RAW MATERIAL COST(Y)
Fallen by -22.19% (YoY
CASH AND EQV(HY)
Highest at CNY 950.75 MM
NET PROFIT(Q)
Highest at CNY 40.13 MM
-14What is not working for the Company
NET SALES(Q)
At CNY 835.44 MM has Fallen at -23.1%
ROCE(HY)
Lowest at 4.44%
INVENTORY TURNOVER RATIO(HY)
Lowest at 5.38 times
DEBTORS TURNOVER RATIO(HY)
Lowest at 3.19 times
Here's what is working for Anhui Fengyuan Pharmaceutical Co., Ltd.
Net Profit
Highest at CNY 40.13 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (CNY MM)
Cash and Eqv
Highest at CNY 950.75 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Raw Material Cost
Fallen by -22.19% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Anhui Fengyuan Pharmaceutical Co., Ltd.
Net Sales
At CNY 835.44 MM has Fallen at -23.1%
Year on Year (YoY)MOJO Watch
Near term sales trend is extremely negative
Net Sales (CNY MM)
Inventory Turnover Ratio
Lowest at 5.38 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Debtors Turnover Ratio
Lowest at 3.19 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
Footer loading
